Hong Kong Stock Exchange filings indicate that on August 6, Morgan Stanley reduced its stake in NOVOSENSE (02676) by 15,687 shares, with a per-share price of approximately HK$136.21, totaling around HK$2.1367 million.
Following this reduction, the institution's current shareholding stands at roughly 1.1969 million shares, equating to a 5.95% ownership stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.